Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,792Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Valcyte

02 2Valcyte/Cymevene

PharmaCompass

01

Brand Name : Valcyte

Ganciclovir and Valganciclovir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Valcyte

arrow
2024 ACI Convention
Not Confirmed

Ganciclovir and Valganciclovir

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2014 Revenue in Millions : 4.80%

2013 Revenue in Millions :

Growth (%) :

blank

02

Brand Name : Valcyte/Cymevene

Ganciclovir And Valganciclovir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Valcyte/Cymevene

arrow
2024 ACI Convention
Not Confirmed

Ganciclovir And Valganciclovir

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2016 Revenue in Millions : 303

2015 Revenue in Millions : 365

Growth (%) : -17

blank

03

Brand Name : Valcyte/Cymevene

Ganciclovir and Valganciclovir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Valcyte/Cymevene

arrow
2024 ACI Convention
Not Confirmed

Ganciclovir and Valganciclovir

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2017 Revenue in Millions : 249

2016 Revenue in Millions : 324

Growth (%) : -23

blank